BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 35632709)

  • 1. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.
    de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO
    Viruses; 2022 May; 14(5):. PubMed ID: 35632709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The research progress of Chikungunya fever.
    Cai L; Hu X; Liu S; Wang L; Lu H; Tu H; Huang X; Tong Y
    Front Public Health; 2022; 10():1095549. PubMed ID: 36699921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
    Lo Presti A; Cella E; Angeletti S; Ciccozzi M
    Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
    Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
    PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Vaccines for Chikungunya Fever.
    Erasmus JH; Rossi SL; Weaver SC
    J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines.
    Bettis AA; L'Azou Jackson M; Yoon IK; Breugelmans JG; Goios A; Gubler DJ; Powers AM
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010069. PubMed ID: 35020717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral perspectives for chikungunya virus.
    Parashar D; Cherian S
    Biomed Res Int; 2014; 2014():631642. PubMed ID: 24955364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya virus: host pathogen interaction.
    Singh SK; Unni SK
    Rev Med Virol; 2011 Mar; 21(2):78-88. PubMed ID: 21412934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya Virus: Priority Pathogen or Passing Trend?
    Montalvo Zurbia-Flores G; Reyes-Sandoval A; Kim YC
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress on chikungunya virus research.
    An W; Ge N; Cao Y; Sun J; Jin X
    Virol Sin; 2017 Dec; 32(6):441-453. PubMed ID: 29188427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular mechanisms of chikungunya pathogenesis.
    Lum FM; Ng LF
    Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic strategies to control chikungunya virus infection.
    Hucke FIL; Bestehorn-Willmann M; Bugert JJ
    Virus Genes; 2021 Apr; 57(2):133-150. PubMed ID: 33590406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-emergence of Chikungunya virus infection in Eastern India.
    Sengupta S; Mukherjee S; Haldar SK; Bhattacharya N; Tripathi A
    Braz J Microbiol; 2020 Mar; 51(1):177-182. PubMed ID: 31898249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights into Chikungunya Virus Infection and Pathogenesis.
    Kril V; Aïqui-Reboul-Paviet O; Briant L; Amara A
    Annu Rev Virol; 2021 Sep; 8(1):327-347. PubMed ID: 34255544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
    Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A
    Front Immunol; 2020; 11():304. PubMed ID: 32194557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 51 years in of Chikungunya clinical vaccine development: A historical perspective.
    Reyes-Sandoval A
    Hum Vaccin Immunother; 2019; 15(10):2351-2358. PubMed ID: 30735447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Chikungunya in the Americas.
    Yactayo S; Staples JE; Millot V; Cibrelus L; Ramon-Pardo P
    J Infect Dis; 2016 Dec; 214(suppl 5):S441-S445. PubMed ID: 27920170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya Virus: Current Perspectives on a Reemerging Virus.
    Morrison CR; Plante KS; Heise MT
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.
    Langsjoen RM; Haller SL; Roy CJ; Vinet-Oliphant H; Bergren NA; Erasmus JH; Livengood JA; Powell TD; Weaver SC; Rossi SL
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.